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SUMMARY
Klotho is a transmembrane and soluble glycoprotein that governs vascular integrity. Previous studies have demon-
strated reduced serum klotho concentrations in patients with systemic sclerosis (SSc), and it is known that klotho 
deficiency can impair the healing of digital ulcers related to microvessel damage. The aim of this study was to 
evaluate the association between serum klotho levels and nailfold capillaroscopic abnormalities in SSc patients. 
We retrospectively enrolled 54 consecutive patients with SSc diagnosed on the basis of the 2013 EULAR/ACR 
criteria [11 with diffuse SSc; 47 females; median age 68.0 years (IQ 18); median disease duration 11.0 years (IQ 
7)]. Serum klotho concentrations were determined by means of an enzyme-linked immunosorbent assay. 
On the basis of the 2000 classification of Cutolo et al., 14 patients had normal nailfold capillaroscopic findings, 8 
had an early scleroderma pattern, 21 an active scleroderma pattern, and 11 a late scleroderma pattern. The median 
serum klotho concentration was 0.29 ng/mL (IQ 1). Regression analysis of variation showed an inverse correla-
tion between serum klotho concentrations and the severity of the capillaroscopic pattern (p=0.02; t -2.2284), 
which was not influenced by concomitant treatment. Logistic regression did not reveal any significant associa-
tion between the risk of developing digital ulcers and nailfold capillaroscopic patterns, serum klotho levels, or 
concomitant medications. The presence of avascular areas significantly correlated with calcinosis (p=0.006). 
In line with previous studies, our findings confirm that klotho plays a role in preventing microvascular damage 
detected with nailfold capillaroscopy. 
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n	 INTRODUCTION
Systemic sclerosis (SSc) is a connec-tive tissue disease that mainly affects 
middle-aged women and is clinically char-
acterized by a wide range of manifesta-
tions, including Raynaud’s phenomenon, 
skin and visceral fibrosis, digital ulcers 
(DUs), subcutaneous calcinosis and pul-
monary artery hypertension (PAH). Unlike 
that of other connective tissue diseases, 
the pathogenesis of SSc is mainly related 
to endothelial dysfunction and impaired 
reparative processes, with the immune sys-
tem playing a secondary role (1).
Nailfold capillaroscopy is an instrumen-
tal procedure that can detect signs of mi-
crovessel damage in the early phases of the 
disease (2). An altered (scleroderma) capil-
laroscopic pattern therefore has diagnostic 
and prognostic value, and has now been 
included in the SSc classification criteria 
(3, 4).
There is currently much interest in find-
ing biomarkers that allow early detection 
of microvascular damage and predict the 
course of SSc, and, although it is still a 
matter of debate, various molecules have 
been evaluated (5-7). Among them, klotho 
has captured the attention of researchers 
because of its central role in mineralisation, 
electrolytic balance, insulin sensitivity, cell 
renewal and reparative processes. Some 
studies have found that SSc patients have 
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lower serum klotho concentrations than 
healthy controls, albeit without any asso-
ciation with clinical manifestations (8-10). 
However, no previous study has attempted 
to evaluate the association between serum 
klotho levels and nailfold capillaroscopic 
images in SSc patients.
n	 MATERIALS AND METHODS
Patients
We retrospectively evaluated 54 consecu-
tive patients diagnosed as having SSc on the 
basis of the 2013 EULAR/ACR criteria (4). 
They were randomly selected from a previ-
ous study designed to evaluate serum klotho 
concentrations in SSc patients (local Ethics 
Committee No. 88 of 5 February 2015) (10). 
All of the patients gave their informed con-
sent to the study analyses and procedures.
A record was made of their demographic 
and clinical characteristics, including dis-
ease severity assessed using the Medsger’s 
scale (11) and skin fibrosis assessed using 
the modified Rodnan skin score (mRSS), 
pulmonary and cardiac involvement 
[forced vital capacity (FVC), diffusing 
capacity/transfer factor of the lung for car-
bon monoxide per unit of alveolar volume 
(DLCO/AV), high-resolution computed 
chest tomography (HRCT), and 2D echo-
cardiography (2D-ECHO)], the results of 
laboratory tests [serum creatinine level, 
erythrocyte sedimentation rate (ESR), C-
reactive protein (CRP), and autoantibod-
ies], and concomitant treatments.
All of the patients underwent a nailfold cap-
illaroscopic examination, and the acquired 
images were reviewed by two independent 
investigators. Capillaroscopic patterns were 
considered normal or not according to the 
size, distribution, number and shape of the 
capillaries (12). Scleroderma patterns were 
scored on the basis of the classification by 
Cutolo et al. (13). Briefly, after applying a 
drop of cedar oil on the cuticles of the 2nd, 
3rd, 4th and 5th fingers, nailfold capillaros-
copy was performed using an optical mi-
croscope with a magnification lens of 200x 
to analyse four consecutive areas of 1 mm 
(14), and the presence of avascular areas 
(the lack of capillaries in an area of 500 µm) 
or decreased capillary density, megacapil-
laries (giant loops with a diameter >50 µm), 
and neo-angiogenesis (arborescent capillar-
ies) was recorded. A numeric score was ar-
bitrarily assigned to capillaroscopic patterns 
(0= normal; 1 = early scleroderma pattern; 2 
= active scleroderma pattern; 3 = late sclero-
derma pattern). 
Laboratory analyses
Venous blood samples were collected from 
each patient, centrifuged, and the serum 
concentration of soluble klotho was meas-
ured by means of an enzyme-linked immu-
nosorbent assay (ELISA) with a sensitivity 
of 0.1 ng/mL using a monoclonal anti-KL 
antibody and a KL-HRP conjugate (My 
Biosource, San Diego, CA, USA).
Statistical analysis
The demographic, clinical and pharmaco-
logical data were descriptively analysed 
using SPSS statistical software, version 23, 
and are reported as mean values ± stand-
ard deviation (SD) or median values, inter-
quartile (IQ) and range depending on their 
Gaussian or non-Gaussian distribution. The 
associations between serum klotho concen-
trations and other data were evaluated by 
means of regression analysis [analysis of 
variance (ANOVA)] with the significance 
level set at p<0.05. Pearson’s chi-squared 
test was used to analyse the associations 
between the nominal variables.
n	 RESULTS
Patient characteristics
Fifty-four SSc patients [47 females (87%); 
median age 68.0 years (IQ 18, range 30-79); 
median disease duration 11.0 years (IQ 7, 
range 4-38)], who were diagnosed on the ba-
sis of the 2013 EULAR/ACR criteria, were 
consecutively enrolled between October 
2014 and April 2016. Forty-three (79.6%) 
had a limited form of the disease and 11 
(20.4%) a diffuse form. The mean Medsger’s 
scale score of severity was 4.0±2.2, and the 
median modified Rodnan skin score (mRSS) 
was 4.0 (IQ 5, range 0-23).
Antinuclear antibodies (ANAs) were de-
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able nuclear antigen (ENA) antibodies in 
30 (55.6%), anti-centromere antibodies 
(ACAs) in 27 (50%), anti-SCL70 antibodies 
in 13 (24.1%), and anticardiolipin antibod-
ies (ACLAs) in three (5.6%). Two-D echo-
cardiography showed signs of PAH in seven 
patients (13%), and lung HRTC detected 
pulmonary fibrosis in 22 (40.7%). Nine pa-
tients (16.7%) had DUs, seven (13%) had 
calcinosis. The median ESR was 19.5 mm 
at the first hour (IQ 31; range 2-58), the me-
dian CRP level was 2.25 mg/L (IQ 4; range 
1-24), and the mean serum creatinine level 
was 0.82±0.22 mg/dL. Pulmonary function 
tests showed that mean VC was 99.8±15.5% 
and mean DLCO/AV 81.0±14.2%.
Nailfold capillaroscopy revealed a normal 
pattern in 14 patients (25.9%), an early SSc 
pattern in eight (14.8%), an active SSc pat-
tern in 21 (38.9%), and a late SSc pattern in 
11 (20.4%). Twenty-one patients (38.9%) 
had avascular areas, 35 (64.8%) had at least 
one megacapillary, and 16 (29.6%) showed 
neo-angiogenesis.
Sixteen patients (29.6%) were taking pred-
nisone (2.5-12.5 mg/day), 18 (33.3%) were 
taking calcium channel blockers, and 15 
(27.8%) were taking hydroxychloroquine 
(200-400 mg/day). All of the patients were 
receiving periodic intravenous infusions of 
prostanoids (alprostadil in 29, and iloprost 
in 25).
Table I resumes the demographic and clini-
cal characteristics of the patients.
Klotho concentrations
The median serum klotho concentration 
was 0.29 ng/mL (IQ 1, range 0-2): the 
patients with a normal nailfold capillaro-
scopic pattern had a median concentration 
of 0.89 ng/mL (IQ 1, range 0-2); those 
with an early SSc pattern had a median 
concentration of 0.25 ng/mL (IQ 1, range 
0-1); those with an active SSc pattern had a 
median concentration of 0.25 ng/mL (IQ 1, 
range 0-1); and those with a late SSc pat-
tern had a median concentration of 0.25 ng/
mL (IQ 1, range 0-1).
Regression analysis (ANOVA) showed a 
significant inverse correlation between se-
rum klotho concentrations and the sever-
ity of the capillaroscopic pattern (p=0.02; 
t -2.2284; Figure 1), which was not influ-
enced by concomitant treatment. However, 
they did not significantly correlate with 
the presence of avascular areas, megaca-
pillaries or neo-angiogenesis when each 
of these variables was individually evalu-
ated. Logistic regression did not reveal any 
significant association between the risk of 
developing digital ulcers and the nailfold 
capillaroscopic pattern, serum klotho lev-
els or concomitant medications. Pearson’s 
chi-squared test showed a significant asso-
Table I - Characteristics of the studied patients.
No. of patients 54
Females/males 47/7
Median age, years (IQ, range) 68.0 (18, 30-79)
Limited/diffuse disease 43/11
Median disease duration, years (IQ, range) 11.0 (7, 4-38)
Median Medsger scale score (±SD) 4.0±2.2
Median mRSS (IQ, range) 4.0 (5, 0-23)
ANA positivity, No. (%) 53 (98.1%)
ACA positivity, No. (%) 27 (50%)
Anti-scl-70 antibody positivity, No. (%) 13 (24.1%)
Digital ulcers, No. (%) 9 (16.7%)
Interstitial lung disease, No. (%) 22 (40.7%)
Pulmonary artery hypertension, No. (%) 7 (13%)
Normal/abnormal nailfold capillaroscopic findings 14/40
IQ, interquartile; SD, standard deviation; mRSS, modified Rodnan skin score; 
ANA, anti-nuclear antibody; ACA, anti-centromere antibody.
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ciation between avascular areas detected at 
nailfold capillaroscopy and the presence of 
calcinosis (p=0.006), which is in line with 
the results of previous studies (15). Cal-
cinosis was significantly associated with 
ACA positivity (p=0.04) and the mRSS 
(p=0.02), although these variables did not 
correlate with the capillaroscopic findings. 
n	 DISCUSSION
The pathogenesis of SSc is characterised by 
a complex network of vascular cells, fibro-
blasts and cells belonging to the immune 
system. Endothelial dysfunction and fibrosis 
are both hallmarks of the disease, thus mak-
ing it unique in the spectrum of connective 
tissue diseases; however, reduced perfusion 
related to an imbalance between the factors 
governing vasoconstriction and vasodilata-
tion, as well as to anatomical modifications 
of microvessels, are ultimately responsible 
for Raynaud’s phenomenon, DUs, teleangi-
ectasias, PAH and calcinosis, which reflect 
the global involvement of the microcircula-
tion in different systems (16).
Nailfold capillaroscopy is a non-invasive 
and reliable means of assessing the morpho-
logical characteristics of nailfold capillaries, 
which are part of the terminal circulation 
and may undergo particular changes during 
vasculopathic processes such as those devel-
oping in SSc patients. It is therefore useful 
for detecting early anatomical details sug-
gesting SSc, distinguishing early SSc from 
non-pathological Raynaud’s phenomenon 
(17), and helping physicians to monitor and 
predict the course of the disease. Although 
there is still no good method of quantitative 
scoring, a number of studies have found a 
good correlation between worsening nailfold 
capillaroscopic patterns and visceral organ 
impairment or the risk of developing DUs in 
SSc patients (2). Finally, other studies have 
shown a significant association between spe-
cific capillaroscopic pictures or patterns and 
soluble biomarkers, including vascular en-
dothelial growth factor (VEGF) and cluster 
of differentiation 40 L (CD40L) (5, 18).
Klotho is a single-pass transmembrane 
soluble protein governing vascular stability, 
hydro-electrolytic balance and tissue repair 
(19). It has two isoforms (alpha and beta), 
with alpha-klotho being expressed through-
out the arterial tree and involved in the de-
velopment of vascular ectopic calcifications 
(20, 21). Reduced serum klotho concentra-
tions have been observed in the elderly and 
during end-stage kidney disease, and it has 
been shown that klotho may prevent vaso-
constriction, endothelial dysfunction and 
oxidative stress by regulating Ca2+ ion in-
flux into microvascular cells, as well as the 
concentrations of reactive oxygen species 
(ROS) and nitric oxide (NO) (22, 23). We 
and other authors have previously found a 
deficit in serum soluble klotho in SSc pa-
tients (8, 10), and Mazzotta et al. have re-
cently demonstrated that the addition of sol-
uble alpha-klotho to human microvascular 
endothelial cells in vitro has pro-angioge-
netic effects that allow wound healing (24). 
This is the first study to investigate the as-
sociation between serum klotho levels and 
nailfold capillaroscopic patterns in SSc pa-
tients. We found that low levels were related 
to worse capillaroscopic patterns as classified 
by Cutolo et al., although there were no sig-
nificant associations when avascular areas, 
megacapillaries and neo-angiogenesis were 
considered individually. Our findings also 
confirmed that a late scleroderma pattern was 
associated with calcinosis, ACA positivity, 
and worse mRSS values.
The main limitations of this study are that 
no healthy subjects or those suffering from 
primitive Raynaud’s phenomenon were en-
rolled as control groups, that only the total 
concentration of klotho was evaluated (with-
out distinguishing between alpha- and beta-
klotho or among the soluble, secreted and 
transmembrane isoforms), and that the nail-
fold capillaroscopic images were assessed 
qualitatively rather than quantitatively. More-
over, the standardised range of serum klotho 
concentration is still arbitrary as different 
methodologies have been used in previous 
studies of patients and healthy subjects.
n	 CONCLUSIONS
On the basis of our findings, serum solu-
ble klotho might be considered a potential 










Klotho and nailfold videocapillaroscopy in systemic sclerosis
ORIGINAL
PAPER
in SSc as low levels significantly correlate 
with worse capillaroscopic patterns. Future 
studies are needed in order to ascertain the 
usefulness of soluble klotho in predicting 
the risk of developing DUs or PAH, both 
of which are due to irreversible changes in 
the microvascular tree, or monitoring the 
efficacy of vasodilating therapies.
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